David P. Nicolau, PharmD

Director
Hartford Hospital

Disclosure(s): Shionogi: Grant/Research Support

Poster(s):

• 600 - Cefiderocol is Not Sequestered in an Ex vivo Extracorporeal Membrane Oxygenation (ECMO) Circuit
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET

• 609 - In vivo efficacy of human simulated exposures of cefiderocol (FDC) in combination with ceftazidime/avibactam (CZA) or meropenem (MEM) using in a 72 hour murine thigh infection model
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET

• 626 - Tebipenem Pharmacokinetics and Soft-Tissue Distribution in Diabetic Patients with Lower Extremity Infections using In Vivo Microdialysis
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET

• 1722 - In vivo Activity of Imipenem/XNW4107 Human-Simulated Regimen against Serine Carbapenemase-Producing Acinetobacter baumannii and Pseudomonas aeruginosa in the Neutropenic Murine Thigh Infection Model
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET